172 filings
Page 3 of 9
PRE 14A
qghmtmu15tg c6k
1 Sep 23
Preliminary proxy
4:45pm
8-K
ecks5c c6p
18 Aug 23
Departure of Directors or Certain Officers
4:13pm
NT 10-Q
dcbyai
15 Aug 23
Notice of late quarterly filing
8:26am
424B4
8tul5t7
26 Jul 23
Prospectus supplement with pricing info
5:27pm
8-K
c4m7yull7wvh
26 Jul 23
ZyVersa Therapeutics, Inc. Announces Pricing of $2.1 Million Public Offering
5:11pm
POS EX
3p1jd9t
26 Jul 23
Additional exhibits for listing
4:21pm
EFFECT
wxr54s1747szt1
19 Jul 23
Notice of effectiveness
12:15am
CORRESP
j10hpkzxj6df3a9 0je
14 Jul 23
Correspondence with SEC
12:00am
CORRESP
st6l4k0ufo895b8tf3p0
14 Jul 23
Correspondence with SEC
12:00am
CORRESP
ywsgumb8yjp7 tifdp
14 Jul 23
Correspondence with SEC
12:00am
CORRESP
u9vqw1y 4lat
14 Jul 23
Correspondence with SEC
12:00am
CORRESP
gfmqy2i599 j6j2e
11 Jul 23
Correspondence with SEC
12:00am
CORRESP
lzd3btm7ph0twm
11 Jul 23
Correspondence with SEC
12:00am
CORRESP
wmoptv90fum
11 Jul 23
Correspondence with SEC
12:00am
CORRESP
i03hkx5
11 Jul 23
Correspondence with SEC
12:00am
CORRESP
85nzaw
7 Jul 23
Correspondence with SEC
12:00am
CORRESP
52mhr
7 Jul 23
Correspondence with SEC
12:00am
CORRESP
7a6je0k h7k
7 Jul 23
Correspondence with SEC
12:00am